Featured series 
Profiles of Progress
-
Linda Bilmes is doing the math
Kennedy School budget analyst has made it her life’s mission to elucidate the heavy toll of war: ‘If we don’t account for something, we don’t value it.’
Data Visualization
-
Finding ways to ‘drug the undruggable’ diseases
Greg Verdine’s approach embraces improvisational thinking, ‘crazy stuff,’ and he thinks it may be future of medical research
-
Almost everyone she knew growing up were laborers. Now she researches inactivity.
Epidemiologist I-Min Lee has published hundreds of papers on exercise and heart health in her time with the Harvard Alumni Health Study and the Women’s Health Study
-
‘Shared humanity’ is their call to action, here and there
No letup in doctors’ commitment to easing suffering in world’s danger zones
Video
-
‘It’s through research that we can live longer, healthier lives’
Harvard scientists discuss potential impacts of federal funding cuts — from U.S. brain drain to fewer medical breakthroughs
-
‘Miraculous’ treatments for more patients
David Mooney’s team develops immunotherapies that work across many cancer types
-
Attack of the cells
Duane Wesemann’s lab looks to body’s immune system to understand and treat disorders, allergies
-
Hearing breakthrough
David Corey’s lab closes in on revolutionary interventions to treat hereditary deafness
-
Improving cancer care
Nancy Keating’s team uses healthcare data to study access to treatment across populations
-
HIV resurgence
Epidemiologist Jeff Imai-Eaton warns funding cuts could reverse decades of gains in prevention, care
-
HealthShe studies cell lineage in the eye. Now she’s leaving research lineage of her own.
Award-winning biologist Connie Cepko, who advanced work on vision-threatening disease, passes the torch to scientific successors
-
HealthDemystifying migraine
‘It’s not an imagined headache, and it’s not a mild condition,’ says Michael Moskowitz, Brain Prize recipient for his dogma-defying research
-
HealthAn Alzheimer’s breakthrough 10 years in the making
After latest study, Bruce Yankner’s inbox exploded: ‘I try to get back to everybody … I try to provide hope.’
-
HealthIn the grip of ‘horror and anger,’ Gawande grows more determined
As global health suffers, his focus on patient-first systems feels more urgent than ever
-
HealthReeling in a big scientific discovery
William Kaelin pursued Nobel-winning findings using a fisherman’s instinct
-
Health‘Hopeful message’ on brain disease
Researcher Sanjula Singh has looked at stroke, dementia, late-life depression for years, finds lifestyle changes make big difference
-
Highly sensitive science
David Ginty probes pleasure and pain to shed light on autism and other conditions
-
What might cancer treatment teach us about dealing with retinal disease?
Joan Miller’s innovative thinking led to therapies for macular degeneration that have helped millions, made her better leader
-
Let’s not send low-income students back to the ’80s
Financial aid red tape nearly derailed Susan Dynarski’s undergrad dreams. Now she sees decades of progress under threat.
-
We know exercise is good for you. Why? He‘s working on it.
Expanding on decades of research, a new study seeks to pinpoint movement’s molecular benefits
-
Things money can’t buy — like happiness and better health
That’s according to the Harvard Study of Adult Development, which over its 87-year run has generated data that benefits work on other issues
-
Tips for staying alive, decades in the making
JoAnn Manson has spent her career researching – and highlighting – how everyday choices influence health
-
How just a fishing expedition helped lead to GLP-1
Story of game-changing therapy illustrates crucial role of fundamental research breakthroughs
-
Fighting Alzheimer’s one discovery at a time
‘I was just following the science.’
-
Rewriting genetic destiny
David Liu, Breakthrough Prize recipient, retraces path to an ‘incredibly exciting’ disease fighter: ‘This is the essence of basic science.’
-
Long trail from 1992 discovery to 2024 Nobel
Gary Ruvkun recounts years of research, which gradually drew interest, mostly fueled by NIH grants
